1 / 28

DIABETES MEDICATION UPDATE

DIABETES MEDICATION UPDATE. A. Sami Wood, MS, RD/LD,CDE Center For Diabetes Education OSUMC. What Is Diabetes?. A group of diseases characterized by inappropriate high blood sugar due to defects in the production and/or action of insulin and other hormones.

karim
Télécharger la présentation

DIABETES MEDICATION UPDATE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DIABETESMEDICATION UPDATE A. Sami Wood, MS, RD/LD,CDE Center For Diabetes Education OSUMC

  2. What Is Diabetes? A group of diseases characterized by inappropriate high blood sugar due to defects in the production and/or action of insulin and other hormones.

  3. What is sugar doing in the blood? • Sugar is the body’s main source of energy • The body needs a constant supply of energy • Blood sugar is tightly controlled

  4. Sources of Glucose in the Blood • Outside source: food and drinks • Inside source: liver

  5. Insulin • A hormone made in the pancreas • Prevents blood sugar from going too high - Allows the body to use sugar - Allows the body to store extra sugar

  6. Blood glucose and insulin

  7. Normal Insulin/Glucose Patterns

  8. Basal Insulin • Insulin required to control hepatic glucose output even when fasting. • Accounts for 50% of daily insulin needs.

  9. Bolus Insulin • Insulin required to cover mealtime carbohydrates. • Accounts for the other 50% of insulin needs.

  10. EXUBERA • An inhaled rapid-acting insulin for mealtime blood sugar control • Used in DM1 in combination with a basal insulin • Used in DM2 alone or in combination with a basal insulin and/or pills • Should be taken 0-10 minutes before a meal

  11. A lung function test is required before a patient is started on Exubera and every 6 months thereafter

  12. EXUBERA-Contraindications • Smokers • Patients with Asthma and COPD • Children • Pregnant women

  13. EXUBERA Store • Inhaler and insulin blisters at room temperature in a dry place • Unopened insulin blisters in their foil overlap

  14. EXUBERA Side effects • Hypoglycemia • Mild cough

  15. WHAT ABOUT THE OTHER HORMONES INVOLVED IN BLOOD SUGAR CONTROL?

  16. Glucagon • A hormone made in the pancreas • Prevents blood sugar from going too low - Allows the use of stored sugar - Allows the production of new sugar in the liver

  17. Amylin • A hormone made and released with insulin • Slows the flow of sugar from the stomach to the blood • Keeps the liver from making too much sugar • Helps us feel full

  18. SYMLIN • An injectable hormone replacement for Amylin • Used in patients with DM1 or DM2 who are on insulin • Given immediately before major meals • May reduce needs for meal insulin or sulfonulureas by 50% • Lasts in the body 3 hrs with peak action in 21 min

  19. SYMLIN • Start low and go slow Dose range 2.5 to 20 units • Store opened vials in the refrigerator or at room temperature for up to 28 days

  20. SYMLIN Side effects • Nausea • Hypoglycemia • Possible weight loss

  21. SYMLIN Not appropriate for patients with • Hypoglycemia unawareness • Gastroporesis or on meds affecting gastric motility • A1C >9% • Poor compliance with insulin shots

  22. Hormones made in the intestine in response to sugar in the blood. Augment insulin secretion Slow the flow of sugar from the stomach to the blood Keep the liver from making too much sugar Help us feel full Incretins

  23. BYETTA • An analogue for one of the incretin hormones (GLP-1) • An injectable medicine • Used alone or in combination with metformin, TZD and/or sulfonylureas in patients with DM2. • Given 0-60 minutes before breakfast and supper

  24. BYETTA • Available in 5 and 10 mcg pens • Opened pens are only good for 30 days.

  25. BYETTA Side effects • Nausea • Hypoglycemia especially when used with sulfonylureas • Possible weight loss

  26. BYETTA Not appropriate for patients with • Gastroporesis or on meds affecting gastric motility • A1C >9% • Severe liver or kidney disease

  27. Galvus and Januvia Galvus: coming soon Januvia: available • Stabilize one of the incretins (GLP-1) • Used alone or in combination with metformin and/or TZD in patients with DM2. • A once a day pill. • No weight loss or gain observed.

  28. More options for better diabetes management with more freedom and flexibility

More Related